treated with GA had a much lower rate of decrease in memory function. Thus, relapsing-remitting EAE unfavorably influences short-term memory and early GA treatment partially protects against memory ... with unrelenting…
Statement of the Problem: Multiple sclerosis (M.S) is a chronic, immune-mediated, relapsing-remitting disorder affecting young adults, which its pathogenesis is still largely unknown. Multiple sclerosis is the commonest
demyelination, gliosis and neuronal loss. The disease course can be relapsing-remitting or progressive type. Symptoms of Multiple Sclerosis are extremely varied and depend on location and severity of lesion
amount of nerve damage and the nerves affected. Most people with multiple sclerosis take a course in relapsing-remitting disease. They experience periods of new symptoms or relapses that develop ... years. Small…
mortality. Otolaryngologic symptoms are common in multiple sclerosis; however, they are often overlooked. In many cases, they follow the relapsing-remitting phases of the disease, and may spontaneously disappear, leading
immunomodulatory treatments, primary- (PPMS) and secondary-progressive multiple sclerosis (SPMS) were thought to have significantly less intrathecal inflammation than relapsing-remitting (RRMS) MS. Using functional…
disease modifying therapies for the treatment of multiple sclerosis, there are still patients who suffer from severe neurological dysfunction in the relapsing-remitting or early progressive forms of the disease…
Multiple sclerosis is an inflammatory, demyelinating disease of the central nervous system. Most patients have a relapsing-remitting disease type, for which medicines are mostly dedicated. Clinical course of some…
Multiple Sclerosis (MS) is a neuroinflammatory and immune-mediated chronic disease of the Central Nervous System which progressively damages the axonal myelin sheath, leading to axonal transmission impairment…
machinery as an innovative strategy to suppress MS. Benign multiple sclerosis (BMS) occurs in about 15% of patients with relapsing-remitting MS (RRMS) that over time do not develop significant
abnormalities are frequently observed in advanced stages of Multiple Sclerosis (MS). Their frequency increases from clinically isolated syndromes, to relapsing-remitting and secondary progressive MS. The most frequently…
different mechanisms contribute to different subtypes of multiple sclerosis (MS). A unifying concept proposes that patients with both relapsing-remitting MS (RRMS) and primary progressive MS (PPMS) have premature thymic
multifactorial etiology involving genetic and environmental factors on three basic clinical forms of behavior: Relapsing-remitting, secondary progressive and primary progressive. Classical descriptions in the nineteenth…
Introduction: Monoclonal antibodies (MABs) are one of the preferred treatments for multiple sclerosis (MS) due to their target specificity and usually high efficacy. These have usually targeted the immune system…
effect, we used a murine model for multiple sclerosis, the experimental autoimmune encephalomyelitis (EAE) induction, using MOG35-55 immunization with a relapsing-remitting course. AMSCs were previously treated with LPA1
Background: This Multiple Sclerosis (MS) is a Central Nervous System (CNS) disease characterized by demyelination or axonal loss encompassing several clinical subtypes—Relapsing-Remitting MS (RRMS)…
impaired mitochondrial function has been implicated in the pathogenicity of multiple sclerosis (MS), a chronic inflammatory, demyelinating, and neurodegenerative disease of the CNS. We investigated whether variants in…
with Multiple Sclerosis (MS); nevertheless, previous studies reported lower PA rates among these patients as compared to healthy subjects. Our study aims to assess PA in Relapsing-remitting
Multiple sclerosis is a chronic, complex disease with a variety of clinical symptoms and affects mainly young and middle ... aged people. Research and therapies are focused on the early phase of MS, especially…
Recent studies propose that multiple sclerosis (MS) is not only a demyelinating disorder but a primary degenerative disease accompanied with whole brain atrophy. Brain atrophy, indeed, might happen without ... clinic…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.